These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 18271701)

  • 1. Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties.
    Wu A; Oh S; Wiesner SM; Ericson K; Chen L; Hall WA; Champoux PE; Low WC; Ohlfest JR
    Stem Cells Dev; 2008 Feb; 17(1):173-84. PubMed ID: 18271701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
    Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
    Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].
    Song WC; Fei XF; Dong J
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines.
    Qiang L; Yang Y; Ma YJ; Chen FH; Zhang LB; Liu W; Qi Q; Lu N; Tao L; Wang XT; You QD; Guo QL
    Cancer Lett; 2009 Jun; 279(1):13-21. PubMed ID: 19232461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
    Srivastava VK; Nalbantoglu J
    Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phenotype of SHG-44 glioma stem cell spheres and pathological characteristics of their xenograft tumors].
    Wu TF; Chen JM; Chen SS; Chen GL; Wei YX; Xie XS; Du ZW; Zhou YX
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):726-31. PubMed ID: 24378091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.
    Rebetz J; Tian D; Persson A; Widegren B; Salford LG; Englund E; Gisselsson D; Fan X
    PLoS One; 2008 Apr; 3(4):e1936. PubMed ID: 18398462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantation of GL261 neurospheres into C57/BL6 mice: a more reliable syngeneic graft model for research on glioma-initiating cells.
    Yi L; Zhou C; Wang B; Chen T; Xu M; Xu L; Feng H
    Int J Oncol; 2013 Aug; 43(2):477-84. PubMed ID: 23708048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemoresistance of CD133(+) tumor stem cells from human brain glioma].
    Bi CL; Fang JS; Chen FH; Wang YJ; Wu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):568-73. PubMed ID: 17767043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
    Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
    Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
    Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
    Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells.
    Barrantes-Freer A; Renovanz M; Eich M; Braukmann A; Sprang B; Spirin P; Pardo LA; Giese A; Kim EL
    PLoS One; 2015; 10(6):e0130519. PubMed ID: 26086074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
    Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.
    Ogden AT; Waziri AE; Lochhead RA; Fusco D; Lopez K; Ellis JA; Kang J; Assanah M; McKhann GM; Sisti MB; McCormick PC; Canoll P; Bruce JN
    Neurosurgery; 2008 Feb; 62(2):505-14; discussion 514-5. PubMed ID: 18382330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The VHL tumor suppressor protein regulates tumorigenicity of U87-derived glioma stem-like cells by inhibiting the JAK/STAT signaling pathway.
    Kanno H; Sato H; Yokoyama TA; Yoshizumi T; Yamada S
    Int J Oncol; 2013 Mar; 42(3):881-6. PubMed ID: 23338840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
    Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
    Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells.
    Yang Q; Zhang T; Wang C; Jiao J; Li J; Deng Y
    Eur J Pharm Biopharm; 2014 Nov; 88(3):737-45. PubMed ID: 25460146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
    Haghpanah V; Fallah P; Naderi M; Tavakoli R; Soleimani M; Larijani B
    Life Sci; 2016 Feb; 146():34-9. PubMed ID: 26772823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy.
    Tamura K; Aoyagi M; Ando N; Ogishima T; Wakimoto H; Yamamoto M; Ohno K
    J Neurosurg; 2013 Nov; 119(5):1145-55. PubMed ID: 23991844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.